This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 May;3(5):250-1.

doi: 10.1038/ncpneuro0471. Epub 2007 Mar 20.

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia

Caroline H Williams-Gray¹, Roger A Barker

Affiliations

PMID: 17375057
DOI: 10.1038/ncpneuro0471

Comment

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia

Caroline H Williams-Gray et al. Nat Clin Pract Neurol. 2007 May.

. 2007 May;3(5):250-1.

doi: 10.1038/ncpneuro0471. Epub 2007 Mar 20.

Authors

Caroline H Williams-Gray¹, Roger A Barker

Affiliation

¹ Cambridge Centre for Brain Repair, Cambridge, UK.

PMID: 17375057
DOI: 10.1038/ncpneuro0471

No abstract available

PubMed Disclaimer

Comment in

Pharmacotherapy of neuropsychiatric symptoms: opportunities, challenges and current prospects.
Rabins PV, Lyketsos CG. Rabins PV, et al. Nat Clin Pract Neurol. 2007 May;3(5):239. doi: 10.1038/ncpneuro0492. Nat Clin Pract Neurol. 2007. PMID: 17479071 No abstract available.

Comment on

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Burn D, et al. Mov Disord. 2006 Nov;21(11):1899-907. doi: 10.1002/mds.21077. Mov Disord. 2006. PMID: 16960863 Clinical Trial.

Publication types

Actions

Grants and funding

G-4054/PUK_/Parkinson's UK/United Kingdom

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.